← SynDRA
CINOXACIN
SynDRA canonical compound SYN0004579 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | urinary tract infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CA2
- TOP2A
- TOP2B
- gyrA
- gyrB
Mechanisms of action (all sources)
- topoisomerase inhibitor
- gyrA INHIBITOR
- gyrB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- OPRK1
- NR3C1
- NR1I2
- NPY1R
- MLNR
- MC4R
- MC3R
- MBNL1
- MAOA
- LMNA
- KDM4E
- KDM4A
- KCNH2
- HTR3A
- HTR2C
- HTR2B
- OPRD1
- OPRM1
- HTR1A
- PDE3A
- TDP1
- TBXA2R
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SAMHD1
- PTH1R
- PTGS2
- POLI
- PMP22
- PGR
- PDE4D
- HTR2A
- HRH2
- ADORA2A
- CHRM3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Infective Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- CINOBAC
- cinobac
- cinobactin
- Cinoxacine
- Cinoxacino
- 64716
- NSC-304467
- Cinobac
- Cinobactin
- Cinoxacinum
- Cinx
- Clinoxacin
- Uronorm
- Azolinic Acid
- C 8645
- Lilly 64716
- TNP00246
- Cinobac (TN)
- Cinoxacine [INN-French]
- Cinoxacino [INN-Spanish]
- Cinoxacinum [INN-Latin]
- Cinoxacin (JAN/USP/INN)
- Cinoxacin [USAN:BAN:INN:JAN]
- LMK22VUH23
- NSC 304467
- CHEBI:3716
- DTXCID202822
- Acid, Azolinic
- cinoxacina
- RefChem:56762
- J01MB06
- Compound 64716
- MLS000069630
- SMR000058232
- NSC304467
- NCGC00015277-02
- CAS-28657-80-9
Look up CINOXACIN in the interactive SynDRA portal →